S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3‐mediated programmed death‐ligand 1 expression in colorectal cancer

BACKGROUND: Programmed death‐ligand 1 (PD‐L1) has functional roles in cancer stem‐like cell (CSC) phenotypes and chemoresistance besides immune evasion. Chemotherapy is a common treatment choice for colorectal cancer (CRC) patients; however, chemoresistance limits its effectiveness of treatment. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Hye‐Young, Cho, Jaebeom, Sim, Jeong Yeon, Boo, Hye‐Jin, Lee, Ji‐Sun, Lee, Seon‐Boon, Lee, Young‐Jin, Kim, Sung Joo, Kim, Kyu‐Pyo, Park, In‐Ja, Hong, Seung‐Mo, Zhang, Xue‐Li, Zhang, Zhi‐Gang, Park, Rang‐Woon, Lee, Ho‐Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299575/
https://www.ncbi.nlm.nih.gov/pubmed/35858011
http://dx.doi.org/10.1002/ctm2.986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299575/
https://www.ncbi.nlm.nih.gov/pubmed/35858011
http://dx.doi.org/10.1002/ctm2.986

Ejemplares similares